Electron Capture in 163Ho and Overlap plus Exchange Corrections and the Neutrino Mass

Autor: Faessler, Amand, Gastaldo, Loredana, Simkovic, M. F.

Holmium 163 offers perhaps the best chance to determine the neutrino mass by electron capture. This contribution treats the electron capture in 163 Holmium completely relativistic for the overlap and exchange corrections and the description of the bo

Externí odkaz: http://arxiv.org/abs/1407.6504

Venous thromboembolism in patients with chronic lymphocytic leukemia

Autor: Šimkovič, M., Vodárek, P., Motyčková, M., Belada, D., Vrbacký, F., Žák, P., Smolej, L.

Publikováno v: In Thrombosis Research December 2015 136(6):1082-1086

Interaction of a copper(II)–Schiff base complexes with calf thymus DNA and their antimicrobial activity

Autor: Sabolová, D., Kožurková, M., Plichta, T., Ondrušová, Z., Hudecová, D., Šimkovič, M., Paulíková, H., Valent, A.

Publikováno v: In International Journal of Biological Macromolecules 2011 48(2):319-325

Frontline treatment with the combination obinutuzumab±chlorambucil for chronic lymphocytic leukemia outside clinical trials: results of a multinational, multicenter study by ERIC and the Israeli CLL study group

Autor: Herishanu Y, Shaulov A, Fineman R, BasiC-Kinda S, Aviv A, Wasik-Szczepanek E, Jaksic O, Zdrenghea M, Greenbaum U, Mandac I, Simkovic M, Morawska M, Benjamini O, Spacek M, Nemets A, Bairey O, Trentin L, Ruchlemer R, Laurenti L, Ciocan O, Doubek M, Shvidel L, Dali N, Miras F, De Meuter A, Dimou M, Mauro F, Coscia M, Bumbea H, Szasz R, Tadmor T, Gutwein O, Gentile M, Scarfo L, Tedeschi A, Sportoletti P, Vazquez E, Marquet J, Assouline S, Papaioannou M, Braester A, Levato L, Gregor M, Rigolin G, Loscertales J, Perez A, Nijziel M, Popov V, Collado R, Slavutsky I, Itchaki G, Ringelstein S, Goldschmidt N, Perry C, Levi S, Polliack A, Ghia P

Publikováno v: AMERICAN JOURNAL OF HEMATOLOGY
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname

In recent years, considerable progress has been made in frontline therapy for elderly/physically unfit patients with CLL. The combination of obinutuzumab and chlorambucil (O-Clb) has been shown to prolong progression free survival (PFS, median PFS-31

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::807185497322b84d08591ef37660403b
https://fundanet.fihgu.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1598

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.